✦ LIBER ✦

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months

✍ Scribed by Alfonso Carmona; Félix Omeñaca; Juan C. Tejedor; Jose M. Merino; Tejaswini Vaman; Ilse Dieussaert; Paul Gillard; Javier Arístegui

Book ID: 116962830
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 307 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.06.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an AS03A-ad

Immunogenicity and safety of an AS03A-adjuvanted H5N1 influenza vaccine in a Taiwanese population

✍ Shinn-Jang Hwang; Shan-Chwen Chang; Chong-Jen Yu; Yu-Jiun Chan; Tzeng-Ji Chen; S 📂 Article 📅 2011 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 333 KB

Immunogenicity and safety of AS03-adjuva

Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents

✍ J. Garcia-Sicilia; P. Gillard; A. Carmona; J.C. Tejedor; J. Aristegui; J.M. Meri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 949 KB

Safety and immunogenicity of an adjuvant

Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children

✍ Prasad S. Kulkarni; K. Manjunath; Sharad Agarkhedkar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Safety and immunogenicity of a 2009 infl

Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients

✍ Paungpaga Lertdumrongluk; Siribha Changsirikulchai; Chutatip Limkunakul; Poonsuk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Immunogenicity and Efficacy in Hemodialy

Immunogenicity and Efficacy in Hemodialysis Patients of an AS03A-Adjuvanted Vaccine for 2009 Pandemic Influenza A(H1N1): A Nonrandomized Trial

✍ Ralf Dikow; Isabella Eckerle; Dorothea Ksoll-Rudek; Heidrun Hampel; Vedat Schwen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 820 KB

Safety and immunogenicity of 2010–2011 H

Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study

✍ Joanne M. Langley; David W. Scheifele; Caroline Quach; Otto G. Vanderkooi; Brian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 213 KB